Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 6/20 | 0.60 |
| ▸ | SRC | P12931 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10948100 | 0.92 | CES1 (0.56) | CES1SRCTSHRALDH1A1TDP1 | |
| SCHEMBL10944759 | 0.92 | CES1 (0.53) | CES1SRCALDH1A1TDP1LMNA | |
| SCHEMBL16994154 | 0.85 | ACHE (0.46) | CES1SRCTSHRALDH1A1TDP1 | |
| SCHEMBL2033994 | 0.84 | CES1 (0.52) | CES1SRCTSHRALDH1A1TDP1 | |
| Benzoin SCHEMBL15910700 | 0.83 | CES1 (0.64) | CES1SRCTSHRALDH1A1TDP1 | |
| SCHEMBL8332006 | 0.83 | CES1 (0.60) | CES1SRCTSHRALDH1A1TDP1 | |
| SCHEMBL3661644 | 0.83 | CES1 (0.60) | CES1SRCTSHRALDH1A1TDP1 | |
| SCHEMBL10712634 | 0.81 | TDP1 (0.52) | CES1ALDH1A1TDP1CES2LMNA | |
| SCHEMBL50469 | 0.81 | CES1 (0.58) | CES1SRCTSHRALDH1A1TDP1 | |
| SCHEMBL2150284 | 0.80 | CES1 (0.62) | CES1SRCTSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11066602-B2 | Reactive mesogen and liquid crystal composition including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-07-20 | — | — | US | disclosed |
| US-11053354-B2 | Liquid crystal display device | SHARP KABUSHIKI KAISHA (JP) | 2021-07-06 | — | — | US | disclosed |
| US-11009750-B2 | Liquid crystal display device and method for producing liquid crystal display device | SHARP KABUSHIKI KAISHA (JP) | 2021-05-18 | — | — | US | disclosed |
| US-20200050077-A1 | OPTICAL SHUTTER FOR CAMERA MODULE AND PRODUCTION METHOD THEREOF | SHARP KABUSHIKI KAISHA (JP) | 2020-02-13 | — | — | US | disclosed |
| US-20190276741-A1 | REACTIVE MESOGEN AND LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-12 | — | — | US | disclosed |
| US-20190271886-A1 | CURVED LIQUID CRYSTAL DISPLAY DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2019-09-05 | — | — | US | disclosed |
| US-20190227387-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR PRODUCING LIQUID CRYSTAL DISPLAY DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2019-07-25 | — | — | US | disclosed |
| US-10344213-B2 | Reactive mesogen and liquid crystal composition including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-09 | — | — | US | disclosed |
| US-10338436-B2 | Method of manufacturing curved liquid crystal display device and curved liquid crystal display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-02 | — | — | US | disclosed |
| US-9941543-B2 | Non-aqueous liquid electrolyte for secondary battery and secondary battery | FUJIFILM CORPORATION (JP) | 2018-04-10 | — | — | US | disclosed |
| US-8148541-B2 | Rhodanine derivatives, a process for the preparation thereof and pharmaceutical composition containing the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2012-04-03 | — | — | US | disclosed |
| US-20090042872-A1 | Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2009-02-12 | — | — | US | disclosed |
| US-20080095847-A1 | STIMULUS-RELEASE CARRIER, METHODS OF MANUFACTURE AND METHODS OF TREATMENT | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2008-04-24 | — | — | US | disclosed |
| EP-1728838-B1 | Ink composition for ink jet-recording and method for preparing lithographic printing plate using the same | FUJIFILM CORP (JP) | 2007-08-15 | — | — | EP | disclosed |
| US-4960746-A | A-HYDROXY-OR A-AMINO-ACETOPHENONES AND A TITANOCENE COMPOUND SUBSTITUTED BY FLUORINE | CIBA-GEIGY CORPORATION (US) | 1990-10-02 | — | — | US | disclosed |
| US-4321118-A | Bis benzoyl sensitizers for photopolymerization or photo cross linking process and composition | CIBA-GEIGY CORPORATION (US) | 1982-03-23 | — | — | US | disclosed |
| US-4318791-A | PHOTOPOLYMERIZABLE SYSTEM FOR INKS | CIBA-GEIGY CORPORATION (US) | 1982-03-09 | — | — | US | disclosed |
| US-4315807-A | Sensitizers for photopolymerization | CIBA-GEIGY CORPORATION (US) | 1982-02-16 | — | — | US | disclosed |
| US-4308400-A | AROMATIC HYDROXY KETONES | CIBA-GEIGY A.G. (CH) | 1981-12-29 | — | — | US | disclosed |
| EP-0003002-A2 | Use of aromatic-aliphatic ketones as photoinitiators, photopolymerisable systems containing such ketones and aromatic-aliphatic ketones | CIBA-GEIGY AG (CH) | 1979-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11066602-B2 | Reactive mesogen and liquid crystal composition including the same | SPIN2B, ZYX, ZP1 | CES1 4282/4885SRC 349/4885TSHR 4693/4885 |
| US-20080095847-A1 | STIMULUS-RELEASE CARRIER, METHODS OF MANUFACTURE AND METHODS OF TREATMENT | TNF, RYR2, IL1B | CES1 1362/4885SRC 919/4885TSHR 2182/4885 |
| US-20090042872-A1 | Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same | PTPRR, PTPRG, PTPRS | CES1 1016/4885SRC 365/4885TSHR 144/4885 |
| US-10344213-B2 | Reactive mesogen and liquid crystal composition including the same | SCO2, CCNL2, CCNB2 | CES1 893/4885SRC 1260/4885TSHR 1110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.